We discovered that the hyperactivation of the PI3K-AKT signaling pathway, HDAC9, and BCL2 contributed to the sustained state of MEF2D fusion (+) BCP-ALL. This evidence concerns the gene BCL2 and acute lymphoblastic leukemia.